The trading price of Impact BioMedical Inc (AMEX:IBO) floating lower at last check on current market day and closing at $0.44, -7.37% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $0.4444 and $0.4777. In examining the 52-week price action we see that the stock hit a 52-week high of $6.17 and a 52-week low of $0.46. Over the past month, the stock has lost -27.08% in value.
Impact BioMedical Inc, whose market valuation is $5.12 million at the time of this writing, is expected to release its quarterly earnings report in May. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0 per share this quarter, however they have predicted annual earnings per share of 0 for current year and 0 for next year.
A quick review shows that IBO’s price is currently -68.36% off the SMA20 and -70.29% off the SMA50. The RSI metric on the 14-day chart is currently showing 40.95, and weekly volatility stands at 24.02%. When measured over the past 30 days, the indicator reaches 55.75%. Impact BioMedical Inc (AMEX:IBO)’s beta value is currently sitting at 0, while the Average True Range indicator is currently displaying 0.46.
To see how Impact BioMedical Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: IBO stock’s performance was -7.37% in the latest trading.
An evaluation of the daily trading volume of Impact BioMedical Inc (AMEX:IBO) indicates that the 3-month average is 6.03 million. However, this figure has increased over the past 10 days to an average of 18.35.
Currently, records show that 11.50 million of the company’s shares remain outstanding. The insiders hold 15.55% of outstanding shares, whereas institutions hold 0.77%. The stats also highlight that short interest as of 2025-03-31, stood at 0.12 million shares, resulting in a short ratio of 0.01 at that time. From this, we can conclude that short interest is 179.00 of the company’s total outstanding shares. It is noteworthy that short shares in March were up slightly from the previous month’s figure, which was 9293.0. However, since the stock’s price has seen -69.32% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
